Key clinical point: When breast milk isn’t an option, Nutramigen formula might be the next best bet for infants with neonatal abstinence syndrome.
Major finding: There were no differences in NICU admissions, morphine use, or hospital lengths of stay in a review of 92 infants who were fed Nutramigen, versus 99 fed breast milk.
Study details: Review of outcomes in 191 infants.
Disclosures: Mead Johnson, the maker of Nutramigen, funded the work. The lead investigator is a speaker for the company.
REPORTING FROM PAS 2019